HIF-1α signaling regulates LSC maintenance, quiescence and therapy sensitivity by promoting expression of VEGF, CXCR4, CXCL12 and SCF on both the AML blasts and the stromal cells (139). Here, CXCL12 is linked to acute myeloid leukemia.